Not trying to be a downramper (how times have changed) but I am...

Not trying to be a downramper (how times have changed) but I am left asking why didn't we do the Juvenile Animal Study (JAS) in the meantime?

Someone replied to my comment yesterday and said NNZ 2591 has never been trialled in newborns and it makes sense to pump the brakes. Surely if you work in pharma land you would know about JAS and might assume that one is needed?

I know its easy to critique in hindsight and Monday morning quarterback but it is one aspect of the announcement that has my nose out of joint. Surely we could have done that. When JP talks about safety and manufacturing work in the background, I would have thought that this would be part of that, not just for HIE but for all conditions.

Not as if we don't have the money to fund it...